Latest Regulatory Investigation News

Rent.com.au has locked in up to $5.5 million in growth capital by underwriting the exercise of its remaining listed options, positioning the company for accelerated profitability and expansion of its RentBond® loan book.

ANZ Group Holdings reported a 10% decline in cash profit for FY2025 despite an 8% rise in operating income, maintaining its dividend amid significant restructuring and regulatory costs.

Block, Inc. reported a modest 2% revenue increase in Q3 2025 driven by growth in its Cash App and Square segments, alongside a $461.5 million net income. The company issued $2.2 billion in senior notes and repurchased $1.5 billion in stock, while navigating ongoing regulatory scrutiny and legal challenges.

Australian authorities have executed a search warrant at WiseTech Global's Sydney office amid an investigation into alleged insider trading involving the company's founder and employees. No charges have been filed, and the company pledges full cooperation.

Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.

NexGen Energy Ltd. has launched a significant dual equity financing, successfully upsizing its Australian offering and targeting combined proceeds exceeding C$1 billion. This move underscores the company's strategic capital expansion across North American and Australian markets.

Green Critical Minerals has locked in a $5.2 million underwriting agreement to support the exercise of its expiring options, reinforcing its commercialisation strategy for innovative VHD graphite technology.

Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.

Phoslock Environmental Technologies reports a sharp revenue increase driven by Brazil and international markets, yet continues to face significant losses and ongoing legal challenges.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

Dubber Corporation Limited reported a 9% increase in revenue to $42.19 million for FY25, alongside a significant reduction in net loss. However, challenges remain with a major contract non-renewal and ongoing efforts to recover $26.6 million in misused funds.

AF Legal Group Ltd reported a robust 27% increase in revenue to $27.6 million for FY25, propelled by key acquisitions and operational expansion, despite one-off costs impacting statutory profits.